Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Metronidazole Dosing for C. difficile Infection

Treatment Algorithm Based on Disease Severity

  • The Infectious Diseases Society of America recommends vancomycin 125 mg orally four times daily for 10 days or fidaxomicin 200 mg twice daily for 10 days as first-line therapy for non-severe CDI 1, 3
  • For non-severe CDI, metronidazole 500 mg orally three times daily for 10 days can be used as an alternative when vancomycin or fidaxomicin is unavailable 2, 4
  • Vancomycin 125 mg orally four times daily for 10 days or fidaxomicin 200 mg twice daily for 10 days is recommended for severe CDI 3, 5
  • For fulminant CDI, vancomycin 500 mg orally four times daily plus intravenous metronidazole 500 mg every 8 hours is recommended 4

Recurrent CDI Treatment

  • For first recurrence of CDI, vancomycin 125 mg four times daily for 10 days is recommended if metronidazole was used for the initial episode 6
  • For second or subsequent recurrences of CDI, metronidazole should not be used due to the risk of cumulative neurotoxicity, and vancomycin in a tapered/pulsed regimen or other alternatives should be used instead 2, 6

Important Considerations for Metronidazole Use

  • Treatment duration with metronidazole may need to be extended to 14 days in patients with delayed response 1
  • Metronidazole can cause side effects such as metallic taste 3

Monitoring and Follow-up

  • Testing for cure is not recommended, and treatment should continue until clinical symptoms resolve 1

REFERENCES